"Le Centre Hospitalier de Montauban regroupe plusieurs unités d'activités proposant les spécialités médicales et chirurgicales, obstétricales et psychiatriques ainsi que des prestations d'hébergement pour les personnes âgées. Il offre un environnement médico-technique et hôtelier performant, apportant une réponse adaptée en matière de diagnostic, de soins et de conditions de séjour. Figurant parmi les premiers employeurs de la ville de Montauban et pôle de formation départemental pour les personnels paramédicaux, le centre hospitalier est un acteur important de l'économie locale."

During the past decade, CH de Montauban conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH de Montauban" #1 sponsor was "University Hospital, Toulouse" with 8 trials, followed by "Centre Hospitalier Departemental Vendee" with 6 trials sponsored, "Agennix" with 2 trials sponsored, "BioMérieux" with 2 trials sponsored and "Centre Hospitalier Universitaire de Nīmes" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH de Montauban" #1 collaborator was "Ministry of Health, France" with 7 trials as a collaborator, "University Hospital, Tours" with 6 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator, "Poitiers University Hospital" with 2 trials as a collaborator and "Agence Régionale de la Santé - Midi Pyrénées" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "CH de Montauban" are "Acute Respiratory Failure" (3 trials), "Severe Sepsis" (3 trials), "Ventilator-associated Pneumonia" (3 trials), "Critical Illness" (2 trials) and "Sepsis" (2 trials). Many other conditions were trialed in "CH de Montauban" in a lesser frequency.

Most popular intervention types in "CH de Montauban" are "Drug" (13 trials), "Other" (12 trials), "Device" (4 trials), "Procedure" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Endotracheal tubes allowing SSD" (3 trials), "Endotracheal tubes not allowing SSD" (3 trials), "Placebo" (3 trials), "Talactoferrin alfa" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "CH de Montauban" are 38 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CH de Montauban". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in CH de Montauban, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in CH de Montauban, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".